Biochemical analysis and subcellular distribution of E-cadherin-catenin in adenocarcinomas of the gastro-oesophageal junction

Anticancer Research

Volumn 24, Issue 3 A, 2004, Pages 1369-1375

  Wijnhoven, B P L ^a   Tucker, E T ^b   Dinjens, W N M ^a   Tilanus, H W ^a   Pignatelli, M ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Adenocarcinoma; E cadherin catenin; Gastrooesophageal junction

Indexed keywords

ALPHA CATENIN; BETA CATENIN; PLAKOGLOBIN; TRITON X 100; UVOMORULIN;

ADULT; AGED; ARTICLE; CELL ADHESION; CELLULAR DISTRIBUTION; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CYTOPLASM; CYTOSKELETON; ESOPHAGUS CARCINOMA; FEMALE; GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOWER ESOPHAGUS SPHINCTER; MALE; NETHERLANDS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STOMACH ADENOCARCINOMA; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; ALPHA CATENIN; BETA CATENIN; BLOTTING, WESTERN; CADHERINS; CARDIA; CYTOSKELETAL PROTEINS; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; STOMACH NEOPLASMS; SUBCELLULAR FRACTIONS; TRANS-ACTIVATORS;

EID: 3242722412     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-5, 1991.
2. Takeichi M: The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development 102: 639-55, 1988.
3. Riethmacher D, Brinkmann V and Birchmeier C: A targeted mutation i n the mouse E-cadherin gene results in defective preimplantation development. Proc Natl Acad Sci USA 92: 855-9, 1995.
4. Nagafuchi A and Takeichi M: Cell binding function of E-cadherin is regulated by the cytoplasmic domain. EMBO J 7: 3679-84, 1988.
5. Oyama T, Kanai Y, Ochiai A, Akimoto S, Oda T, Yanagihara K, Nagafuchi A, Tsukita S, Shibamoto S, Ito F et al: A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res 54: 6282-7, 1994.
6. Ozawa M, Ringwald M and Kemler R: Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci USA 87: 4246-50, 1990.
7. Breen E, Clarke A, Steele G Jr and Mercurio AM: Poorly differentiated colon carcinoma cell lines deficient in alpha-catenin expression express high levels of surface E-cadherin but lack Ca(2+)-dependent cell-cell adhesion. Cell Adhes Commun 1: 239-50, 1993.
8. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D and Birchmeier W: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-85, 1991.
9. Vleminckx K, Vakaet L Jr, Mareel M, Fiers W and van Roy F: Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66: 107-19, 1991.
10. Perl AK, Wilgenbus P, Dahl U, Semb H and Christofori G: A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392: 190-3, 1998.
11. Blok P, Craanen ME, Dekker W and Tytgat GN: Loss of E-cadherin expression in early gastric cancer. Histopathology 34: 410-5, 1999.
12. Pignatelli M, Ansari TW, Gunter P, Liu D, Hirano S, Takeichi M, Kloppel G and Lemoine NR: Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol 174: 243-8, 1994.
13. Valizadeh A, Karayiannakis AJ, el-Hariry I, Kmiot W and Pignatelli M: Expression of E-cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120) in colorectal polyps. Am J Pathol 150: 1977-84, 1997.
14. Devesa SS, Blot WJ and Fraumeni JF Jr: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83: 2049-53, 1998.
15. Dolan K, Sutton R, Walker SJ, Morris AI, Campbell F and Williams EM: New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology. Br J Cancer 80: 834-42, 1999.
16. Hansson LE, Sparen P and Nyren O: Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer 54: 402-7, 1993.
17. Powell J and McConkey CC: The rising trend in oesophageal adenocarcinoma and gastric cardia. Eur J Cancer Prev 1: 265-9, 1992.
18. Wijnhoven BP, Siersema PD, Hop WC, van Dekken H and Tilanus HW: Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group. Br J Surg 86: 529-35, 1999.
19. Pasdar M and Nelson WJ: Kinetics of desmosome assembly in Madin-Darby canine kidney epithelial cells: temporal and spatial regulation of desmoplakin organization and stabilization upon cell-cell contact. I. Biochemical analysis. J Cell Biol 106: 677-85, 1988.
20. Jawhari AU, Noda M, Pignatelli M and Farthing M: Up-regulated cytoplasmic expression, with reduced membranous distribution, of the src substrate p120(cm) in gastric carcinoma. J Pathol 189: 180-185, 1999.
21. Jankowski JA, Wright NA, Meltzer SJ, Triadafilopoulos G, Geboes K, Casson AG, Kerr D and Young LS: Molecular evolution of the metaplasia-dysplasia- adenocarcinoma sequence in the esophagus. Am J Pathol 154: 965-73, 1999.
22. Bailey T, Biddlestone L, Shepherd N, Barr H, Warner P and Jankowski J: Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia- adenocarcinoma sequence: correlation with disease progression and dedifferentiation. Am J Pathol 152: 135-44, 1998.
23. Krishnadath KK, Tilanus HW, van Blankenstein M, Hop WC, Kremers ED, Dinjens WN and Bosman FT: Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. J Pathol 182: 331-8, 1997.
24. Washington K, Chiappori A, Hamilton K, Shyr Y, Blanke C, Johnson D, Sawyers J and Beauchamp D: Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas. Mod Pathol 11: 805-13, 1998.
25. Bian YS, Osterheld MC, Bosman FT, Fontolliet C and Benhattar J: Nuclear accumulation of beta-catenin is a common and early event during neoplastic progression of Barrett oesophagus. Am J Clin Pathol 114: 583-90, 2000.
26. Seery JP, Syrigos KN, Karayiannakis AJ, Valizadeh A and Pignatelli M: Abnormal expression of the E-cadherin-catenin complex in dysplastic Barrett's oesophagus. Acta Oncol 38: 945-8, 1999.
27. Wijnhoven BP and Pignatelli M: E-cadherin-catenin: more than a "sticky" molecular complex. Lancet 354: 356-7, 1999.
28. Wijnhoven BP, Dinjens WN and Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 87: 992-1005, 2000.
29. Beavon IR: The E-cadherin-catenin complex in tumour metastasis. structure, function and regulation. Eur J Cancer 36: 1607-20, 2000.
30. Nelson WJ, Shore EM, Wang AZ and Hammerton RW: Identification of a membrane-cytoskeletal complex containing the cell adhesion molecule uvomorulin (E-cadherin), ankyrin, and fodrin in Madin-Darby canine kidney epithelial cells. J Cell Biol 110: 349-57, 1990.
31. Nathke IS, Hinck L, Swedlow JR, Papkoff J and Nelson WJ: Defining interactions and distributions of cadherin and catenin complexes in polarized epithelial cells. J Cell Biol 125: 1341-52, 1994.
32. Kimura Y, Shiozaki H, Doki Y, Yamamoto M, Utsunomiya T, Kawanishi K, Fukuchi N, Inoue M, Tsujinaka T and Monden M: Cytoplasmic beta-catenin in esophageal cancers. Int J Cancer 84: 174-8, 1999.
33. Hugh TJ, Dillon SA, O'Dowd G, Getty B, Pignatelli M, Poston GJ and Kinsella AR: beta-catenin expression in primary and metastatic colorectal carcinoma. Int J Cancer 82: 504-11, 1999.
34. Caca K, Kolligs FT, Ji X, Hayes M, Qian J, Yahanda A, Rimm DL, Costa J and Fearon ER: Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Cell Growth Differ 10: 369-76, 1999.
35. Vermeulen SJ, Nollet F, Teugels E, Philippe J, Speleman F, van Roy FM, Bracke ME and Mareel MM: Mutation of alpha-catenin results in invasiveness of human HCT-8 colon cancer cells. Ann NY Acad Sci 833: 186-9, 1997.
36. Machado JC, Soares P, Carneiro F, Rocha A, Beck S, Blin N, Berx G and Sobrinho-Simoes M: E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest 79: 459-65, 1999.
37. Wijnhoven BP, de Both NJ, van Dekken H, Tilanus HW and Dinjens WN: E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus. Br J Cancer 80: 1652-7, 1999.
38. Wijnhoven BP, Nollet F, De Both NJ, Tilanus HW and Dinjens WN: Genetic alterations involving exon 3 of the beta-catenin gene do not play a role in adenocarcinomas of the esophagus. Int J Cancer 86: 533-7, 2000.
39. Behrens J, Vakaet L, Friis R, Winterhager E, Van Roy F, Mareel MM and Birchmeier W: Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol 120: 757-66, 1993.
40. Matsuyoshi N, Hamaguchi M, Taniguchi S, Nagafuchi A, Tsukita S and Takeichi M: Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts. J Cell Biol 118: 703-14, 1992.
41. Nawrocki B, Polette M, Van Hengel J, Tournier JM, Van Roy F and Birembault P: Cytoplasmic redistribution of E-cadherin-catenin adhesion complex is associated with down-regulated tyrosine phosphorylation of E-cadherin in human bronchopulmonary carcinomas. Am J Pathol 153: 1521-30, 1998.
42. Serini G, Trusolino L, Saggiorato E, Cremona O, De Rossi M, Angeli A, Orlandi F and Marchisio PC: Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue. J Natl Cancer Inst 88: 442-9, 1996.